Total Payments
$842.69
2024 Payments
$237.14
Companies
19
Transactions
26
Medicare Patients
1,008
Medicare Billing
$114,777
Payment Breakdown by Category
Food & Beverage$674.71 (80.1%)
Education$167.98 (19.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $674.71 | 24 | 80.1% |
| Education | $167.98 | 2 | 19.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $187.88 | 3 | $0 (2023) |
| ABBVIE INC. | $128.99 | 2 | $0 (2024) |
| Amgen Inc. | $117.55 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $66.60 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $49.01 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $45.20 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $24.11 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $23.71 | 1 | $0 (2024) |
| ARRAY BIOPHARMA INC | $22.59 | 1 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $21.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.14 | 11 | Novartis Pharmaceuticals Corporation ($49.01) |
| 2023 | $382.98 | 11 | Pharmacyclics LLC, An AbbVie Company ($119.89) |
| 2022 | $37.03 | 2 | ARRAY BIOPHARMA INC ($22.59) |
| 2021 | $185.54 | 2 | Amgen Inc. ($117.55) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Oncology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Oncology | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Oncology | ||||||
| 07/23/2024 | PFIZER INC. | INLYTA (Drug), TALZENNA, XTANDI | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 04/02/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: BioOncology | ||||||
| 03/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Oncology | ||||||
| 02/28/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Oncology | ||||||
| 11/15/2023 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $101.83 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2023 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 10/24/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.95 | General |
| Category: Hematology | ||||||
| 10/19/2023 | Ipsen Biopharmaceuticals, Inc | Tazverik (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Oncology | ||||||
| 10/05/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Oncology | ||||||
| 05/08/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| Category: Oncology | ||||||
| 03/21/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.13 | General |
| 02/21/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: Hematology/Oncology | ||||||
| 12/09/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Oncology | ||||||
| 07/15/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, PAXLOVID | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 12/22/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Education | In-kind items and services | $67.99 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 309 | 501 | $52,017 | $30,005 |
| 2022 | 3 | 311 | 500 | $55,926 | $36,795 |
| 2021 | 2 | 229 | 440 | $48,600 | $32,984 |
| 2020 | 2 | 159 | 276 | $27,909 | $14,993 |
Total Patients
1,008
Total Services
1,717
Medicare Billing
$114,777
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 207 | 361 | $37,331 | $21,166 | 56.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 50 | 68 | $9,891 | $5,943 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 52 | 72 | $4,795 | $2,897 | 60.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 148 | 229 | $31,373 | $20,950 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 129 | 220 | $21,340 | $13,647 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 34 | 51 | $3,213 | $2,198 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 134 | 292 | $28,324 | $18,393 | 64.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 95 | 148 | $20,276 | $14,591 | 72.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 134 | 251 | $24,484 | $13,123 | 53.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 25 | 25 | $3,425 | $1,870 | 54.6% |
About Julie Huss, NP
Julie Huss, NP is a Acute Care healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548591043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julie Huss, NP has received a total of $842.69 in payments from pharmaceutical and medical device companies, with $237.14 received in 2024. These payments were reported across 26 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($674.71).
As a Medicare-enrolled provider, Huss has provided services to 1,008 Medicare beneficiaries, totaling 1,717 services with total Medicare billing of $114,777. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Albany, NY
- Active Since 01/22/2010
- Last Updated 05/10/2021
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1548591043
Products in Payments
- IMBRUVICA (Drug) $167.98
- EPKINLY (Drug) $121.73
- LYNPARZA (Drug) $45.20
- OPDUALAG (Drug) $43.47
- PIQRAY (Drug) $27.17
- VENCLEXTA (Drug) $27.16
- Enhertu (Drug) $24.11
- Vyloy (Drug) $23.71
- BRAFTOVI (Drug) $22.59
- KISQALI (Drug) $21.84
- XPOVIO (Drug) $21.82
- JAKAFI (Drug) $21.37
- ERLEADA (Drug) $20.45
- REBLOZYL (Biological) $16.95
- INLYTA (Drug) $16.38
- Stivarga (Drug) $16.38
- Tazverik (Drug) $15.85
- BRUKINSA (Drug) $14.44
- Phesgo (Biological) $13.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Albany
Mrs. Michele Biscossi, Acnp-Cs, Ms, Rn, ACNP-CS, MS, RN
Acute Care — Payments: $61,601
Acute Care $61,601
Darshaney Sankhar, Np, NP
Acute Care — Payments: $3,902
Acute Care $3,902
Dale Webster, Np, NP
Acute Care — Payments: $2,988
Acute Care $2,988
Mrs. Loretta Nerney, Acnp-Bc, ACNP-BC
Acute Care — Payments: $1,424
Acute Care $1,424
Mr. Dewayne Cecil, Agacnp, AGACNP
Acute Care — Payments: $1,269
Acute Care $1,269
Melissa Andersen, Np, NP
Acute Care — Payments: $1,193
Acute Care $1,193